Use of intravenous brivaracetam in status epilepticus: A multicenter registry.

Estevo SantamarinaBeatriz Parejo CarbonellJacint SalaÁlvaro Gutiérrez ViedmaJúlia MiróMontserrat AsensioLaura AbrairaMercé FalipJoaquín OjedaFrancisco Javier López-GonzálezXiana Rodríguez-OsorioJosé Ángel MauriMaria AiguabellaIrene García MoralesManuel Toledo

Published in: Epilepsia (2019)

BRV is useful for the treatment of SE, even when patients are already being treated with LEV. The response rate seems higher when it is administered earlier and at higher doses (>1.82 mg/kg).

Keyphrases

end stage renal disease
newly diagnosed
ejection fraction
chronic kidney disease
peritoneal dialysis
prognostic factors
high dose
patient reported outcomes
smoking cessation